Real-World Pilots Aimed at Reducing Missed Dialysis Treatments and Improving Patient Experience DALLAS (March 25, 2015) – DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the… Read more

Year Marked by Continued Clinical Excellence, Commitment to Patient Services, Innovative Partnerships, International Growth, Community Leadership Denver (Dec. 29, 2014) – DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider… Read more

MINNEAPOLIS (Dec. 15, 2014) – DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation’s largest and most innovative health care communities, today announced that two of its business units,… Read more

PHILADELPHIA (Nov. 10, 2014) – DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company representatives and collaborators… Read more

LAS VEGAS (April 22, 2014) – DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company… Read more

ANAHEIM, Calif., (April 14, 2014) – DaVita Clinical Research (DCR) (NYSE: DVA), a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced… Read more

MINNEAPOLIS (Feb. 12, 2014) – DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device development, announced today that it has… Read more

MINNEAPOLIS (Dec. 19, 2013) – DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device development, announced today a non-exclusive agreement… Read more

“Inspired to Give” Campaign Highlights Altruistic Nature of Participants DENVER (Nov. 27, 2013) – DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of… Read more

LAS VEGAS (April 22, 2013) – DaVita Clinical Research® (DCR®) (NYSE: DVA), a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced… Read more